Phibro Animal Health Corp. (PAHC)
35.31
-1.01
(-2.78%)
USD |
NASDAQ |
Aug 24, 16:00
35.36
+0.05
(+0.14%)
After-Hours: 20:00
Phibro Animal Health EPS Diluted (Quarterly) : 0.5854 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 0.5854 |
| December 31, 2025 | 0.6704 |
| September 30, 2025 | 0.649 |
| June 30, 2025 | 0.4232 |
| March 31, 2025 | 0.5129 |
| December 31, 2024 | 0.0782 |
| September 30, 2024 | 0.1719 |
| June 30, 2024 | 0.0185 |
| March 31, 2024 | 0.2074 |
| December 31, 2023 | 0.0314 |
| September 30, 2023 | -0.1979 |
| June 30, 2023 | 0.2839 |
| March 31, 2023 | 0.2479 |
| December 31, 2022 | 0.178 |
| September 30, 2022 | 0.0952 |
| June 30, 2022 | 0.1849 |
| March 31, 2022 | 0.4367 |
| December 31, 2021 | 0.4312 |
| September 30, 2021 | 0.1613 |
| June 30, 2021 | 0.4222 |
| March 31, 2021 | 0.3002 |
| December 31, 2020 | 0.316 |
| September 30, 2020 | 0.3037 |
| June 30, 2020 | 0.1383 |
| March 31, 2020 | 0.3333 |
| Date | Value |
|---|---|
| December 31, 2019 | 0.2936 |
| September 30, 2019 | 0.0621 |
| June 30, 2019 | 0.2173 |
| March 31, 2019 | 0.3664 |
| December 31, 2018 | 0.3639 |
| September 30, 2018 | 0.4022 |
| June 30, 2018 | 0.5457 |
| March 31, 2018 | 0.49 |
| December 31, 2017 | 0.17 |
| September 30, 2017 | 0.39 |
| June 30, 2017 | 0.38 |
| March 31, 2017 | 0.59 |
| December 31, 2016 | 0.34 |
| September 30, 2016 | 0.31 |
| June 30, 2016 | 0.38 |
| March 31, 2016 | 0.46 |
| December 31, 2015 | 0.75 |
| September 30, 2015 | 0.47 |
| June 30, 2015 | 0.26 |
| March 31, 2015 | 0.42 |
| December 31, 2014 | 0.39 |
| September 30, 2014 | 0.52 |
| June 30, 2014 | -0.47 |
| March 31, 2014 | 0.0924 |
| December 31, 2013 | 0.0334 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Zoetis, Inc. | 1.654 |
| Merck & Co., Inc. | -0.5405 |
| ANI Pharmaceuticals, Inc. | 1.052 |
| Corcept Therapeutics, Inc. | 0.356 |
| Veru, Inc. | -0.3032 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 24.02M |
| Revenue (Quarterly) | 383.54M |
| Total Expenses (Quarterly) | 359.52M |
| Enterprise Value | 2.142B |
| Gross Profit Margin (Quarterly) | 32.56% |
| Profit Margin (Quarterly) | 6.26% |
| Earnings Yield | 6.59% |
| Operating Earnings Yield | 12.73% |
| Normalized Earnings Yield | 7.114 |